Axios reports: The plan from the House Energy and Commerce Committee would establish a new oversight process for certain risky pathogen research proposals and transfer power from NIH to a “public, independent oversight entity” to review, approve or reject and oversee the experiments. It also would incorporate national security or intelligence reviews into the NIH’s existing grant approval process, add …
Read More »